Treatment of lymphangioleiomyomatosis with the MEK1/2 inhibitor CI-1040 delayed the development of primary tumors and blocked the estrogen-induced lung metastases in treated animals. Such treatment also reduced the number of circulating ELT3 cells and decreased their lung colonization after intravenous injection.
Legal claims defining the scope of protection. Each claim is shown in both the original legal language and a plain English translation.
Claims not yet imported for this patent.
Claims are being imported from USPTO data. Check back soon!
Cooperative Patent Classification codes for this invention. Click any code to explore related patents in that topic.
May 20, 2009
September 10, 2013
Browse 5M+ US patents with plain-English claim translations and AI-generated analysis.